Arcutis Biotherapeutics, Inc.
← Back to ARQT Overview

Arcutis Biotherapeutics, Inc. (ARQT)

Profitability & Net Margin History

Current Net Margin

13.43%

Arcutis Biotherapeutics, Inc. currently has a net profit margin of 13.43%.

Financial Fundamentals

ARQTQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.130.0213.43%596
2025-09-300.100.017.47%2696
2025-06-300.08-0.02-19.49%1857
2025-03-310.07-0.03-38.06%2294
2024-12-310.07-0.01-15.12%7769
2024-09-300.04-0.04-92.81%7678
2024-06-300.03-0.05-169.59%9821
2024-03-310.05-0.04-71.38%41867
2023-12-310.01-0.07-490.05%37258
2023-09-300.04-0.04-117.47%125038
2023-06-300.01-0.07-1367.84%149936
2023-03-310.00-0.08-2867.21%43495
2022-12-310.00-0.07-2432.25%1242416
2022-09-300.00-0.11-14856.41%
2022-06-300.00-0.07
2022-03-310.00-0.06
2021-12-310.00-0.07
2021-09-300.00-0.06
2021-06-300.00-0.04
2021-03-310.00-0.04
2020-12-310.00-0.03
2020-09-300.00-0.04
2020-06-300.00-0.04
2020-03-310.00-0.03
2019-12-310.00-0.01
2019-09-300.00-0.01
2019-06-300.00-0.01
2019-03-310.00-0.01
2018-12-310.00-0.01
2018-09-300.00-0.01
2018-06-300.00-0.00
2018-03-310.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.